Glasgow/Wetlab

From 2007.igem.org

(Difference between revisions)
Line 44: Line 44:
*'''PCR with new primers associated with DntR and XylR.'''
*'''PCR with new primers associated with DntR and XylR.'''
|
|
-
* '''*m and *s cloned into TOPO vectors.'''
+
* '''phzM and phzS cloned into TOPO vectors.'''
*'''Primer design for 7 gene operon.'''
*'''Primer design for 7 gene operon.'''
*'''DntR cloned into TOPO vector.'''
*'''DntR cloned into TOPO vector.'''
Line 59: Line 59:
|
|
*'''Suspected amplification of 7 gene operon.'''
*'''Suspected amplification of 7 gene operon.'''
-
* '''*m and *s confirmed as present in TOPO vectors.'''
+
* '''phzM and phzS confirmed as present in TOPO vectors.'''
*'''Confirmed presence of death gene plasmid in some vectors.'''
*'''Confirmed presence of death gene plasmid in some vectors.'''
*'''Miller assay performed with DntR system.'''
*'''Miller assay performed with DntR system.'''
*'''Yeast cells.'''
*'''Yeast cells.'''
|
|
-
*'''Biobricks made of (*m), (*s), and DntR.'''
+
*'''Biobricks made of phzM, phzS, and DntR.'''
|- align="center"
|- align="center"
Line 74: Line 74:
|
|
*'''Utilised new biobricks.'''
*'''Utilised new biobricks.'''
-
*'''Site directed mutagenesis of (*m) completed.'''
+
*'''Site directed mutagenesis of phzM completed.'''
|
|
-
*'''Site directed mutagenesis of (*s) completed.'''
+
*'''Site directed mutagenesis of phzS completed.'''
Line 86: Line 86:
|- valign=top
|- valign=top
|
|
-
*'''(*d→g*) successfully cloned into TOPO vector.'''
+
*'''phzD→phzG successfully cloned into TOPO vector.'''
|
|
*'''''Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.'''''
*'''''Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.'''''

Revision as of 14:52, 21 October 2007

https://static.igem.org/mediawiki/2007/thumb/c/cc/Uog.jpg/50px-Uog.jpg Back To
Glasgow's
Main Page
Go To
Glasgow's
Modelling Page

Protocols References Resources Sequences Biobricks
Used
Gels

Click on a week number for more detailed lab book...


Week 1
Week 2
  • First selection of biobricks transformed.
  • Preparation of stocks.
  • Change of plan because DmpR failed to grow.
  • Researched XylR and DntR sensor systems.
  • Designed primers for DmpR, DntR, XylR and associated promoters.
Week 3
Week 4
  • BioBricks tested by digestion and PCR.
  • PCR with new primers associated with DntR and XylR.
  • phzM and phzS cloned into TOPO vectors.
  • Primer design for 7 gene operon.
  • DntR cloned into TOPO vector.
  • Primer design for XylR and associated genes.
  • Death gene cloned into TOPO vector.
  • Primer design for death gene.
Week 5
Week 6
  • Suspected amplification of 7 gene operon.
  • phzM and phzS confirmed as present in TOPO vectors.
  • Confirmed presence of death gene plasmid in some vectors.
  • Miller assay performed with DntR system.
  • Yeast cells.
  • Biobricks made of phzM, phzS, and DntR.
Week 7
Week 8
  • Utilised new biobricks.
  • Site directed mutagenesis of phzM completed.
  • Site directed mutagenesis of phzS completed.


Week 9
Week 10
  • phzD→phzG successfully cloned into TOPO vector.
  • Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Protocols References Resources Orders Biobricks
Used
Gels